Literature DB >> 10349369

Fine needle aspiration biopsy of Hashimoto's thyroiditis. Sources of diagnostic error.

L MacDonald1, H M Yazdi.   

Abstract

OBJECTIVE: To determine the accuracy of cytologic interpretation in the diagnosis of Hashimoto's thyroiditis (HT). STUDY
DESIGN: At Ottawa Hospital from 1987 to 1994, 1,638 fine needle aspiration biopsies (FNABs) from thyroid were performed. HT was suggested in 184 FNAB samples taken from 157 patients. Of the 184 aspirates diagnosed with HT, 39 had corresponding surgical specimens taken from 31 patients. A retrospective review of these FNABs and surgical pathology slides formed the basis of this study.
RESULTS: In 27 (69%) aspirates, HT was diagnosed on both the FNAB and surgical specimens. In 10 of 27 FNABs an associated lesion was not sampled by FNAB. In four of these 10 aspirates some of the cellular features of HT were misinterpreted, and the possibility of an associated neoplasm could not be ruled out. This resulted in four false positive diagnoses. In 12 (31%) FNABs from nine patients, the cytologic diagnosis of HT was not confirmed histologically. These cases included five Hürthle cell adenomas and one case each of follicular adenoma, nodular goiter, macrofollicular adenoma and malignant lymphoma. This resulted in five false negative diagnoses.
CONCLUSION: These results support the value of FNAB in the diagnosis of HT. The presence of hyperplastic follicular cells on FNAB samples from HT may mimic a follicular neoplasm and result in a false positive interpretation. Adequate sampling of the thyroid is important, particularly when there is an associated lesion. The diagnosis of lymphocytic thyroiditis should not be made when only a few lymphocytes are present. Finally, pleomorphic Hürthle cells may be present in aspirates from Hürthle cell neoplasms and underdiagnosed as HT, especially when they are associated with a few lymphocytes.

Entities:  

Mesh:

Year:  1999        PMID: 10349369     DOI: 10.1159/000331088

Source DB:  PubMed          Journal:  Acta Cytol        ISSN: 0001-5547            Impact factor:   2.319


  7 in total

1.  Both thyroid autoimmunity and increased serum TSH are independent risk factors for malignancy in patients with thyroid nodules.

Authors:  F Boi; L Minerba; M L Lai; B Marziani; B Figus; F Spanu; A Borghero; S Mariotti
Journal:  J Endocrinol Invest       Date:  2012-08-29       Impact factor: 4.256

Review 2.  Papillary Thyroid Cancer and Hashimoto's Thyroiditis: An Association Less Understood.

Authors:  Akshay Anand; Kul Ranjan Singh; Jitendra Kumar Kushwaha; Nuzhat Hussain; Abhinav Arun Sonkar
Journal:  Indian J Surg Oncol       Date:  2014-07-04

3.  Association between Thyroiditis and Multifocality in Papillary Thyroid Carcinoma.

Authors:  Rogério Aparecido Dedivitis; Leandro Luongo de Matos; Felipe Guilherme Silva Souza; Jose Luis Bogado Ortiz
Journal:  Int Arch Otorhinolaryngol       Date:  2020-06-23

4.  Surgical Outcome and Malignant Risk Factors in Patients With Thyroid Nodule Classified as Bethesda Category III.

Authors:  Jianhao Huang; Hongyan Shi; Muye Song; Jinan Liang; Zhiyuan Zhang; Xiaohang Chen; Yongchen Liu; Sanming Wang; Zeyu Wu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-14       Impact factor: 5.555

5.  Repeat FNA Significantly Lowers Number of False Negative Results in Patients with Benign Nodular Thyroid Disease and Features of Chronic Thyroiditis.

Authors:  Dorota Słowińska-Klencka; Ewa Woźniak-Oseła; Bożena Popowicz; Stanisław Sporny; Mariusz Klencki
Journal:  Int J Endocrinol       Date:  2014-04-09       Impact factor: 3.257

6.  Causes of misdiagnoses by thyroid fine-needle aspiration cytology (FNAC): our experience and a systematic review.

Authors:  Yanli Zhu; Yuntao Song; Guohui Xu; Zhihui Fan; Wenhao Ren
Journal:  Diagn Pathol       Date:  2020-01-03       Impact factor: 2.644

Review 7.  Challenges in Cytology Specimens With Hürthle Cells.

Authors:  Eleni Thodou; Sule Canberk; Fernando Schmitt
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-25       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.